{"title":"Ferroptosis as a Pathogenic Mechanism and Therapeutic Target in Autoimmune and Inflammatory Skin Diseases.","authors":"Peilong Guo, Fangqi Chen, Ming Zhao","doi":"10.1007/s12016-025-09125-3","DOIUrl":null,"url":null,"abstract":"<p><p>Ferroptosis represents an iron-dependent cell death pathway driven by lipid peroxide accumulation. Recent research has established that ferroptosis is closely linked to the pathogenesis and progression of various autoimmune and inflammatory skin diseases. This article systematically reviews the biological basis of ferroptosis and its specific regulatory characteristics in the skin, focusing on three core mechanisms: iron metabolism, lipid metabolism, and redox homeostasis. It emphasizes the hierarchical, dynamic, and complex nature of the skin, as a barrier organ exposed to the external environment, in maintaining ferroptosis homeostasis. This article focuses on representative diseases such as psoriasis, systemic lupus erythematosus, vitiligo, systemic sclerosis, photodermatoses, and atopic dermatitis. It summarizes the mechanisms by which ferroptosis is involved in skin cell injury, immune activation, inflammation maintenance, and autoantigen exposure. Finally, considering the current research limitations and gaps, the article proposes the potential of ferroptosis as a therapeutic target for autoimmune and inflammatory skin diseases.</p>","PeriodicalId":10423,"journal":{"name":"Clinical Reviews in Allergy & Immunology","volume":"69 1","pages":""},"PeriodicalIF":11.5000,"publicationDate":"2026-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Reviews in Allergy & Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12016-025-09125-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Ferroptosis represents an iron-dependent cell death pathway driven by lipid peroxide accumulation. Recent research has established that ferroptosis is closely linked to the pathogenesis and progression of various autoimmune and inflammatory skin diseases. This article systematically reviews the biological basis of ferroptosis and its specific regulatory characteristics in the skin, focusing on three core mechanisms: iron metabolism, lipid metabolism, and redox homeostasis. It emphasizes the hierarchical, dynamic, and complex nature of the skin, as a barrier organ exposed to the external environment, in maintaining ferroptosis homeostasis. This article focuses on representative diseases such as psoriasis, systemic lupus erythematosus, vitiligo, systemic sclerosis, photodermatoses, and atopic dermatitis. It summarizes the mechanisms by which ferroptosis is involved in skin cell injury, immune activation, inflammation maintenance, and autoantigen exposure. Finally, considering the current research limitations and gaps, the article proposes the potential of ferroptosis as a therapeutic target for autoimmune and inflammatory skin diseases.
期刊介绍:
Clinical Reviews in Allergy & Immunology is a scholarly journal that focuses on the advancement of clinical management in allergic and immunologic diseases. The journal publishes both scholarly reviews and experimental papers that address the current state of managing these diseases, placing new data into perspective. Each issue of the journal is dedicated to a specific theme of critical importance to allergists and immunologists, aiming to provide a comprehensive understanding of the subject matter for a wide readership.
The journal is particularly helpful in explaining how novel data impacts clinical management, along with advancements such as standardized protocols for allergy skin testing and challenge procedures, as well as improved understanding of cell biology. Ultimately, the journal aims to contribute to the improvement of care and management for patients with immune-mediated diseases.